Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: In Silico Analysis
The novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has previously never been identified with humans, thereby creating devastation in public health. The need for an effective vaccine to curb this pandemic cannot be overemphasized. In view o...
Saved in:
| Main Authors: | Onyeka S. Chukwudozie, Rebecca C. Chukwuanukwu, Onyekachi O. Iroanya, Daniel M. Eze, Vincent C. Duru, Temiloluwa O. Dele-Alimi, Busuyi D. Kehinde, Taiwo T. Bankole, Perpetua C. Obi, Elizabeth U. Okinedo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2020/2837670 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preparation of recombinant SARS-CoV-2 nucleocapsid protein
by: A. S. Yakovleva, et al.
Published: (2025-03-01) -
The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
by: Haiyun Yu, et al.
Published: (2023-12-01) -
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories
by: Leslie R. Zwerwer, et al.
Published: (2025-05-01) -
Designing Sandwich ELISA with Broadly Reactive Anti-Nucleocapsid Monoclonal Antibodies to Detect Bat-Borne Merbecoviruses
by: Kong Yen Liew, et al.
Published: (2025-06-01) -
Chemokines simultaneously bind SARS-CoV-2 nucleocapsid protein RNA-binding and dimerization domains
by: Alberto Domingo López-Muñoz, et al.
Published: (2025-03-01)